Breaking News

Enzene Biosciences Expanding to New Jersey Bio Manufacturing Plant

$50 million investment in new, state-of-the-art, 55,000-sq.-ft. facility will bring 300 jobs to the state.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Choose New Jersey, a nonprofit economic development organization, announced that Enzene Biosciences, Ltd., a global biotech company based in Pune, India, will open its state-of-the-art biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell. Operations in the new facility, the company’s first location outside of India, are expected to begin in June 2024.   As a Contract Development and Manufacturing Organization (CDMO), Enzene Biosciences, a subsidiary of Alke...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters